secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001104659-22-114206
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cara Therapeutics appoints Lisa von Moltke, M.D. to Board of Directors
----------------------------------------------------------------------

- Dr. von Moltke is EVP and Chief Medical Officer at Seres Therapeutics, with prior roles at Alkermes and Sanofi.
- She will receive $45K annual cash retainer, $5K for nominating committee, and initial option grant of $350K vesting quarterly over 3 years.
- Appointment effective November 1, 2022; term expires at 2023 Annual Meeting; she will serve on nominating and corporate governance committee.
- Her expertise is expected to support execution of strategy for oral difelikefalin in pruritus, a key pipeline program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465922114206/0001104659-22-114206-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465922114206/tm2229601d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-114206

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer